CD276 and thyroid cancer: Using the TISIDB database, we demonstrated that ALDH1A1/A3/B1 had significant negative correlations with immune-stimulating genes, such as CD276, TMEM173, TNFSF9, CD70, TNFRSF25, and CD40 in thyroid cancer (Figure 7A).